Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Esterified estrogens/methyltestosterone

From Wikipedia, the free encyclopedia
(Redirected fromEstratest)
Pharmaceutical combination
This articleneeds additional citations forverification. Please helpimprove this article byadding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "Esterified estrogens/methyltestosterone" – news ·newspapers ·books ·scholar ·JSTOR
(November 2017) (Learn how and when to remove this message)
Pharmaceutical compound
Esterified estrogens /
methyltestosterone
Combination of
Esterified estrogensEstrogen
MethyltestosteroneAndrogen;Anabolic steroid
Clinical data
Trade namesCovaryx, Essian, Estratest, Menogen, Syntest
Other namesEEs/MT
Routes of
administration
By mouth
Drug classEstrogen;Androgen
ATC code
Legal status
Legal status
Identifiers
CAS Number

Esterified estrogens/methyltestosterone (EEs/MT), sold under brand names such asCovaryx,Eemt,Essian,Estratest,Menogen, andSyntest, is ahormonal preparation that combinesesterified estrogens (EEs) withmethyltestosterone (MT) in one tablet and is used inmenopausal hormone therapy.[2]

Medical uses

[edit]

EEs/MT is used to treatmenopausal women who suffer fromhot flashes, but do not get relief from estrogen-only therapy.

Available forms

[edit]

EEs/MT is sold in tablet form, with either 1.25 mg EEs/2.5 mg MT or 0.625 mg EEs/1.25 mg MT available.

Pharmacology

[edit]

The product is a combination ofesterified estrogens, anestrogen, and low-dosemethyltestosterone, anandrogen/anabolic steroid, in a single tablet.

History

[edit]

EEs/MT was first marketed in the United States in 1965 by Reid-Provident Laboratories, which as 100% of Reid-Rowell, Inc. stock was acquired by the Belgian pharmaceutical companySolvay in 1986. There has been some controversy surrounding the drug in recent years as to its status with the U.S.Food and Drug Administration.

Solvay sponsored a clinical trial of EEs/MT in the United States to determine whether the product is superior to treatment with esterified estrogens tablets.

EEs/MT was supplied by Solvay. In March 2009 Solvay announced that, based on a variety of business factors, it would discontinue supplying Estratest and Estratest HS tablets, and would stop accepting orders for the product on March 31, 2009.

See also

[edit]

References

[edit]
  1. ^"FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.)".nctr-crs.fda.gov.FDA. Retrieved22 Oct 2023.
  2. ^"Esterified Estrogens And Methyltestosterone (Oral Route)".Mayo Clinic. Mayo Foundation for Medical Education and Research.

External links

[edit]


Estrogens
ERTooltip Estrogen receptor agonists
Progonadotropins
Antiestrogens
ERTooltip Estrogen receptor antagonists
(incl.SERMsTooltip selective estrogen receptor modulators/SERDsTooltip selective estrogen receptor downregulators)
Aromatase inhibitors
Antigonadotropins
Others
Androgens
(incl.AASTooltip anabolic–androgenic steroid)
ARTooltip Androgen receptoragonists
Progonadotropins
Antiandrogens
ARTooltip Androgen receptorantagonists
Steroidogenesis
inhibitors
5α-Reductase
Others
Antigonadotropins
Others
ERTooltip Estrogen receptor
Agonists
Mixed
(SERMsTooltip Selective estrogen receptor modulators)
Antagonists
GPERTooltip G protein-coupled estrogen receptor
Agonists
Antagonists
Unknown
ARTooltip Androgen receptor
Agonists
SARMsTooltip Selective androgen receptor modulator
Antagonists
GPRC6A
Agonists
Retrieved from "https://en.wikipedia.org/w/index.php?title=Esterified_estrogens/methyltestosterone&oldid=1269343701"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp